| Name | Title | Contact Details |
|---|
Founded in 1987, Health Level Seven (HL7) is an ANSI-accredited non-profit that empowers global health data interoperability by developing standards and enabling their adoption and implementation – for a world where everyone can securely access and use the right health data when and where they need it.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Austin-based Superior HealthPlan (Superior) is a managed care company that employs more than 3,400 people across nine Texas offices. Superior is a wholly-owned subsidiary of Centene Corporation, a diversified, multi-national healthcare enterprise. Superior is licensed by the Texas Department of Insurance and is a Qualified Health Plan issuer in the Texas Health Insurance Marketplace.
Wellington Place is a North Olmsted, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advanced Biomedical Research is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.